{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:53:36Z","timestamp":1790805216527,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.05.034","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T19:02:13Z","timestamp":1591124533000},"page":"240-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme"],"prefix":"10.1016","volume":"18","author":[{"given":"Jeong-A","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.05.034_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1432-1033.1975.tb03911.x","article-title":"Debranching enzyme from rabbit skeletal muscle. Purification, properties and physiological role","volume":"51","author":"Taylor","year":"1975","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtm.2020.05.034_bib2","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1038\/ncomms11229","article-title":"Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations","volume":"7","author":"Zhai","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.05.034_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-5793(75)80254-7","article-title":"Debranching enzyme from rabbit skeletal muscle; evidence for the location of two active centres on a single polypeptide chain","volume":"58","author":"Bates","year":"1975","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2020.05.034_bib4","series-title":"Glycogen Storage Disease Type III. In GeneReviews, M.P. Adam et\u00a0al., eds.","author":"Dagli","year":"2010"},{"key":"10.1016\/j.omtm.2020.05.034_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10038-006-0045-x","article-title":"Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey","volume":"51","author":"Endo","year":"2006","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2020.05.034_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.034_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","article-title":"Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?","volume":"46","author":"Demo","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2020.05.034_bib9","first-page":"2686","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Genet","volume":"21","author":"Halaby","year":"2019","journal-title":"Med"},{"key":"10.1016\/j.omtm.2020.05.034_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-116-11-896","article-title":"Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy","volume":"116","author":"Coleman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01744800","article-title":"Cardiomyopathy of glycogen storage disease type III","volume":"8","author":"Carvalho","year":"1993","journal-title":"Heart Vessels"},{"key":"10.1016\/j.omtm.2020.05.034_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/GIM.0b013e3181e0e979","article-title":"Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time","volume":"12","author":"Vertilus","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymgme.2017.08.010","article-title":"Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa","volume":"122","author":"Decostre","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.034_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ymgme.2012.09.025","article-title":"Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa","volume":"107","author":"Horvath","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.034_bib15","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/JB.00176-09","article-title":"Role of maltogenic amylase and pullulanase in maltodextrin and glycogen metabolism of Bacillus subtilis 168","volume":"191","author":"Shim","year":"2009","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.omtm.2020.05.034_bib16","first-page":"804","article-title":"Characterization of a canine model of glycogen storage disease type IIIa","volume":"5","author":"Yi","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2020.05.034_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtm.2020.05.034_bib19","first-page":"41","article-title":"Natural Progression of Canine Glycogen Storage Disease Type IIIa","volume":"66","author":"Brooks","year":"2016","journal-title":"Comp. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib20","first-page":"51303","article-title":"Assessing functional performance in the mdx mouse model","volume":"85","author":"Aartsma-Rus","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2020.05.034_bib21","first-page":"e2237","article-title":"Evaluation of Muscle Performance in Mice by Treadmill Exhaustion Test and Whole-limb Grip Strength Assay","volume":"7","author":"Castro","year":"2017","journal-title":"Biol. Protoc"},{"key":"10.1016\/j.omtm.2020.05.034_bib22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/bonekey.2015.101","article-title":"Assessment of muscle mass and strength in mice","volume":"4","author":"Bonetto","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.omtm.2020.05.034_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ymgme.2014.02.005","article-title":"Mouse model of glycogen storage disease type III","volume":"111","author":"Liu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.034_bib24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.bbadis.2014.07.029","article-title":"Glycogen storage disease type III: A novel Agl knockout mouse model","volume":"1842","author":"Pagliarani","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.05.034_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ymthe.2017.12.019","article-title":"Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression","volume":"26","author":"Vidal","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.omtm.2019.01.006","article-title":"Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid \u03b1-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease","volume":"12","author":"Lim","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.05.034_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10545-014-9789-1","article-title":"Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases","volume":"38","author":"Michon","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.034_bib28","first-page":"13","article-title":"Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient","volume":"5","author":"Sentner","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.omtm.2020.05.034_bib29","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.bbadis.2018.07.031","article-title":"Glucose-free\/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice","volume":"1864","author":"Pagliarani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.omtm.2020.05.034_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2012.12.002","article-title":"Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III","volume":"108","author":"Sun","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.034_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00109-014-1127-4","article-title":"Correction of glycogen storage disease type III with rapamycin in a canine model","volume":"92","author":"Yi","year":"2014","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtm.2020.05.034_bib32","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ymthe.2018.04.023","article-title":"Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases","volume":"26","author":"Pursell","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib35","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.2174\/138161211797247569","article-title":"Adeno-associated viral vectors for correction of inborn errors of metabolism: progressing towards clinical application","volume":"17","author":"Jacobs","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omtm.2020.05.034_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/14712598.2012.681463","article-title":"The advent of AAV9 expands applications for brain and spinal cord gene delivery","volume":"12","author":"Dayton","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib37","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.05.034_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/jb.164.2.633-638.1985","article-title":"Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae","volume":"164","author":"Michaelis","year":"1985","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.omtm.2020.05.034_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0005-2744(76)90235-7","article-title":"Purification and properties of a debranching enzyme from Escherichia coli","volume":"438","author":"Jeanningros","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.05.034_bib40","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JB.187.4.1465-1473.2005","article-title":"Role of the Escherichia coli glgX gene in glycogen metabolism","volume":"187","author":"Dauvill\u00e9e","year":"2005","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.omtm.2020.05.034_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1525-0016(03)00022-4","article-title":"Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector","volume":"7","author":"Sun","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/hum.2010.055","article-title":"Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale","volume":"21","author":"Lock","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.034_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"Lynch","year":"2005","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2020.05.034_bib45","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1369\/jhc.7A7239.2007","article-title":"Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model","volume":"55","author":"Taksir","year":"2007","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2020.05.034_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0003-2697(03)00056-3","article-title":"Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry","volume":"316","author":"Young","year":"2003","journal-title":"Anal. Biochem."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:24Z","timestamp":1762421244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"alternative-id":["S2329050120301212"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.034","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}